Best Seeking Alpha Alternatives in March 2026: Quick Picks
March 2026 brings a crowded field of Seeking Alpha alternatives. Traders now weigh real-time data, crowd insights, an...
Which Index Funds For Low Cost Diversification
Low-cost index funds offer broad diversification with minimal fees. This guide explains how to choose funds that track wide market indexes for retirement.
26,677 articles
Singapore Punches Above Weight in Southeast Asia 500
Singapore's companies dominate the Southeast Asia 500 by revenue, capturing roughly a third of the region's total. Th...
Why This Oddity Tech Stock Is Up 7% Today: Buyback Signals
This oddity tech stock is making waves again. With a larger share repurchase plan and improving cash flow, the stock ...
Reasons Lilly Stock: 5 Key Upsides Investors Should Watch
This deep dive looks at why Lilly stock may be a standout pick for growth-focused investors. From a dominant obesity ...
Bamco Expands FactSet Stake, Fueling Recurring Revenue
A recent move shows Bamco expanding its exposure to FactSet, highlighting the power of subscription-based data platfo...
Stock Market Today, June: Sunrun Deal Sparks Rally
As markets navigated a cautious session, Sunrun’s new framework with Tesla and Renew Home pushed renewable energy equ...
BridgeBio (BBIO) 2026 Earnings: Practical Investor Guide
BridgeBio's Q1 2026 earnings narrative is more than quarterly numbers—it's a roadmap for the year ahead. This guide e...
Forget Amazon Prime Days: The Real Stock Buy Opportunity
Promotional events like Prime Day grab headlines, but the real driver of Amazon stock is its cloud arm, AWS. This gui...
How to Build $3,000 a Month in Dividend Income Today
A year-by-year calculation shows how much capital you need to generate $3,000 a month via dividends, with tradeoffs a...
Applied Materials Just Ripped 55% in a Month: Sell?
Applied Materials just ripped higher again, sparking a profit-taking debate as the stock taps fresh highs. This repor...
Missed Nvidia? Missed Tesla? AI Marketing Stock at $0.91
RAD Intel debuts a Regulation A+ offering at $0.91 per share, pitching an AI-driven marketing engine as the next oppo...
Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status